3 Recession-Proof ETFs to Invest in Now
The U.S. gross domestic product (GDP) contracted 0.3% during the…
Buy
77
CPRX Quote, Financials, Valuation and Earnings
Last price:
$23.38
Seasonality move
:
15.63%
Day range:
$22.89 - $23.70
52-week range:
$14.75 - $26.16
Dividend yield:
0%
P/E ratio:
14.89x
P/S ratio:
5.50x
P/B ratio:
3.59x
Volume:
1.6M
Avg. volume:
1.2M
1-year change:
49.33%
Market cap:
$2.9B
Revenue:
$491.7M
EPS (TTM):
$1.57
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $119.1M | $140.8M | $214.2M | $398.2M | $491.7M | |
| Revenue Growth (YoY) | 16.39% | 18.28% | 52.1% | 85.9% | 23.49% | |
| Cost of Revenues | $17M | $21.9M | $34.4M | $52M | $68.8M | |
| Gross Profit | $102M | $118.9M | $179.8M | $346.2M | $422.9M | |
| Gross Profit Margin | 85.69% | 84.46% | 83.94% | 86.95% | 86% | |
| R&D Expenses | $16.5M | $16.9M | $19.8M | $93.2M | $12.6M | |
| Selling, General & Admin | $44.2M | $49.6M | $57.1M | $133.7M | $177.7M | |
| Other Inc / (Exp) | $587K | $282K | $2.9M | $3M | $5.1M | |
| Operating Expenses | $60.7M | $66.6M | $78M | $259.4M | $227.8M | |
| Operating Income | $41.3M | $52.4M | $101.8M | $86.8M | $195.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $41.9M | $52.7M | $104.7M | $94.5M | $216.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$33.1M | $13.2M | $21.6M | $23.1M | $52.4M | |
| Net Income to Company | $75M | $39.5M | $83.1M | $71.4M | $163.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $75M | $39.5M | $83.1M | $71.4M | $163.9M | |
| Basic EPS (Cont. Ops) | $0.72 | $0.38 | $0.80 | $0.67 | $1.38 | |
| Diluted EPS (Cont. Ops) | $0.71 | $0.37 | $0.75 | $0.63 | $1.31 | |
| Weighted Average Basic Share | $103.5M | $103.4M | $103.4M | $106.3M | $118.5M | |
| Weighted Average Diluted Share | $106.2M | $107.8M | $111.4M | $113.8M | $124.9M | |
| EBITDA | $41.4M | $52.6M | $103.1M | $119.7M | $232.9M | |
| EBIT | $41.3M | $52.4M | $101.8M | $86.8M | $195.1M | |
| Revenue (Reported) | $119.1M | $140.8M | $214.2M | $398.2M | $491.7M | |
| Operating Income (Reported) | $41.3M | $52.4M | $101.8M | $86.8M | $195.1M | |
| Operating Income (Adjusted) | $41.3M | $52.4M | $101.8M | $86.8M | $195.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $30.2M | $43.1M | $85.4M | $98.5M | $141.4M | |
| Revenue Growth (YoY) | 3.67% | 42.66% | 98.12% | 15.4% | 43.56% | |
| Cost of Revenues | $4.7M | $5.9M | $9.9M | $12.5M | $17.9M | |
| Gross Profit | $25.5M | $37.2M | $75.4M | $86M | $123.5M | |
| Gross Profit Margin | 84.5% | 86.33% | 88.35% | 87.29% | 87.34% | |
| R&D Expenses | $3M | $3.4M | $3.6M | $2.6M | $3.9M | |
| Selling, General & Admin | $12.7M | $16.4M | $29.7M | $46.9M | $46.9M | |
| Other Inc / (Exp) | $81K | $93K | $1.7M | -$1.1M | $2.6M | |
| Operating Expenses | $15.7M | $19.8M | $39.8M | $58.9M | $60.1M | |
| Operating Income | $9.8M | $17.4M | $35.6M | $27.1M | $63.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $9.9M | $17.5M | $37.3M | $29.1M | $71.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.2M | $4.2M | $7.7M | $5.8M | $14.5M | |
| Net Income to Company | $7.7M | $13.2M | $29.6M | $23.3M | $56.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $7.7M | $13.2M | $29.6M | $23.3M | $56.7M | |
| Basic EPS (Cont. Ops) | $0.07 | $0.13 | $0.28 | $0.20 | $0.47 | |
| Diluted EPS (Cont. Ops) | $0.07 | $0.12 | $0.26 | $0.19 | $0.45 | |
| Weighted Average Basic Share | $103.8M | $102.8M | $105.6M | $116.8M | $121.5M | |
| Weighted Average Diluted Share | $106.7M | $109M | $114M | $123.4M | $127M | |
| EBITDA | $9.9M | $17.4M | $42.2M | $36.6M | $72.8M | |
| EBIT | $9.8M | $17.4M | $35.6M | $27.1M | $63.4M | |
| Revenue (Reported) | $30.2M | $43.1M | $85.4M | $98.5M | $141.4M | |
| Operating Income (Reported) | $9.8M | $17.4M | $35.6M | $27.1M | $63.4M | |
| Operating Income (Adjusted) | $9.8M | $17.4M | $35.6M | $27.1M | $63.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $120.1M | $153.7M | $256.5M | $411.3M | $534.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $17.6M | $23.1M | $38.4M | $54.5M | $74.2M | |
| Gross Profit | $102.6M | $130.6M | $218M | $356.8M | $460.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $15.3M | $17.3M | $19.9M | $92.2M | $14M | |
| Selling, General & Admin | $46.9M | $53.3M | $70.4M | $150.9M | $177.7M | |
| Other Inc / (Exp) | $331K | $294K | $4.5M | $1.9M | $8.9M | |
| Operating Expenses | $62.2M | $70.7M | $98M | $278.5M | $229M | |
| Operating Income | $40.4M | $60M | $120.1M | $78.3M | $231.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $40.7M | $60.2M | $124.6M | $86.3M | $258.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$31.5M | $15.2M | $25.2M | $21.2M | $61.1M | |
| Net Income to Company | $72.2M | $45.1M | $99.4M | $65.1M | $197.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $72.2M | $45.1M | $99.4M | $65.1M | $197.4M | |
| Basic EPS (Cont. Ops) | $0.69 | $0.44 | $0.95 | $0.60 | $1.66 | |
| Diluted EPS (Cont. Ops) | $0.68 | $0.42 | $0.88 | $0.54 | $1.57 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $40.6M | $60.1M | $127.9M | $114M | $269.2M | |
| EBIT | $40.4M | $60M | $120.1M | $78.3M | $231.4M | |
| Revenue (Reported) | $120.1M | $153.7M | $256.5M | $411.3M | $534.6M | |
| Operating Income (Reported) | $40.4M | $60M | $120.1M | $78.3M | $231.4M | |
| Operating Income (Adjusted) | $40.4M | $60M | $120.1M | $78.3M | $231.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $30.2M | $43.1M | $85.4M | $98.5M | $141.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.7M | $5.9M | $9.9M | $12.5M | $17.9M | |
| Gross Profit | $25.5M | $37.2M | $75.4M | $86M | $123.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3M | $3.4M | $3.6M | $2.6M | $3.9M | |
| Selling, General & Admin | $12.7M | $16.4M | $29.7M | $46.9M | $46.9M | |
| Other Inc / (Exp) | $81K | $93K | $1.7M | -$1.1M | $2.6M | |
| Operating Expenses | $15.7M | $19.8M | $39.8M | $58.9M | $60.1M | |
| Operating Income | $9.8M | $17.4M | $35.6M | $27.1M | $63.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $9.9M | $17.5M | $37.3M | $29.1M | $71.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.2M | $4.2M | $7.7M | $5.8M | $14.5M | |
| Net Income to Company | $7.7M | $13.2M | $29.6M | $23.3M | $56.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $7.7M | $13.2M | $29.6M | $23.3M | $56.7M | |
| Basic EPS (Cont. Ops) | $0.07 | $0.13 | $0.28 | $0.20 | $0.47 | |
| Diluted EPS (Cont. Ops) | $0.07 | $0.12 | $0.26 | $0.19 | $0.45 | |
| Weighted Average Basic Share | $103.8M | $102.8M | $105.6M | $116.8M | $121.5M | |
| Weighted Average Diluted Share | $106.7M | $109M | $114M | $123.4M | $127M | |
| EBITDA | $9.9M | $17.4M | $42.2M | $36.6M | $72.8M | |
| EBIT | $9.8M | $17.4M | $35.6M | $27.1M | $63.4M | |
| Revenue (Reported) | $30.2M | $43.1M | $85.4M | $98.5M | $141.4M | |
| Operating Income (Reported) | $9.8M | $17.4M | $35.6M | $27.1M | $63.4M | |
| Operating Income (Adjusted) | $9.8M | $17.4M | $35.6M | $27.1M | $63.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $130.2M | $171.4M | $298.4M | $137.6M | $517.6M | |
| Short Term Investments | $10M | $19.8M | -- | -- | -- | |
| Accounts Receivable, Net | $6M | $6.6M | $10.4M | $53.5M | $65.5M | |
| Inventory | $4.7M | $7.9M | $6.8M | $15.6M | $19.5M | |
| Prepaid Expenses | $7.4M | $3.9M | $4.8M | $12M | $20M | |
| Other Current Assets | $883K | $327K | -- | $351K | $1M | |
| Total Current Assets | $159.2M | $210.1M | $320.8M | $219.3M | $623.6M | |
| Property Plant And Equipment | $130K | $4M | $3.6M | $3.7M | $3.6M | |
| Long-Term Investments | -- | -- | -- | $16.5M | $21.6M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $32.5M | $194M | $156.7M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $192.4M | $237.8M | $375.6M | $470.1M | $851.4M | |
| Accounts Payable | $4.3M | $2.8M | $4M | $14.8M | $16.6M | |
| Accrued Expenses | $14.4M | $19.6M | $26.1M | $38.3M | $88M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $29K | $308K | $337K | $369K | $402K | |
| Other Current Liabilities | $106K | $243K | $238K | $465K | $417K | |
| Total Current Liabilities | $22.8M | $27.1M | $57.6M | $76.1M | $120.7M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $22.8M | $31M | $75.2M | $82.2M | $123.8M | |
| Common Stock | $104K | $103K | $105K | $107K | $121K | |
| Other Common Equity Adj | $31K | -$148K | $24K | $14K | $64K | |
| Common Equity | $169.6M | $206.8M | $300.4M | $387.9M | $727.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $169.6M | $206.8M | $300.4M | $387.9M | $727.6M | |
| Total Liabilities and Equity | $192.4M | $237.8M | $375.6M | $470.1M | $851.4M | |
| Cash and Short Terms | $140.3M | $191.3M | $298.4M | $137.6M | $517.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $127.3M | $178.4M | $148.2M | $310.4M | $580.7M | |
| Short Term Investments | $16M | $19.4M | -- | -- | -- | |
| Accounts Receivable, Net | $5.6M | $10.6M | $33.4M | $60.5M | $71.3M | |
| Inventory | $4.4M | $7.8M | $10.3M | $20M | $19.8M | |
| Prepaid Expenses | $7.6M | $4.4M | $6.4M | $13.6M | $12.6M | |
| Other Current Assets | $276K | $433K | $335K | -- | $452K | |
| Total Current Assets | $161.5M | $221.2M | $198.9M | $404.6M | $685.7M | |
| Property Plant And Equipment | $4.3M | $3.9M | $4M | $3.7M | $3.4M | |
| Long-Term Investments | -- | -- | -- | $15.3M | $24.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $184.1M | $184.7M | $147.3M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $197.2M | $247M | $407.2M | $646.7M | $908.9M | |
| Accounts Payable | $2.6M | $5.1M | $3.4M | $10.3M | $11.2M | |
| Accrued Expenses | $9.7M | $14.1M | $19.8M | $43.9M | $77.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $122K | $316K | $345K | $377K | $410K | |
| Other Current Liabilities | $111K | $141K | $279K | $631K | $2.2M | |
| Total Current Liabilities | $14.4M | $22.9M | $56.7M | $79.6M | $111.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $18.6M | $26.8M | $73.6M | $85.3M | $114.6M | |
| Common Stock | $104K | $103K | $106K | $118K | $122K | |
| Other Common Equity Adj | -$45K | -$453K | $11K | -- | -$17K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $178.7M | $220.2M | $333.7M | $561.4M | $794.3M | |
| Total Liabilities and Equity | $197.2M | $247M | $407.2M | $646.7M | $908.9M | |
| Cash and Short Terms | $143.3M | $197.8M | $148.2M | $310.4M | $580.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $75M | $39.5M | $83.1M | $71.4M | $163.9M | |
| Depreciation & Amoritzation | $92K | $192K | $1.2M | $32.9M | $37.8M | |
| Stock-Based Compensation | $6.3M | $6.1M | $7.9M | $14.3M | $22.3M | |
| Change in Accounts Receivable | $4.5M | -$632K | -$3.8M | -$43.1M | -$12M | |
| Change in Inventories | -$2.7M | -$3.2M | $1.1M | -$4.7M | -$3.9M | |
| Cash From Operations | $45M | $60.4M | $116M | $143.6M | $239.8M | |
| Capital Expenditures | $11K | $1M | $29K | $81.7M | $556K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$5M | -$11M | $9.2M | -$293.5M | -$556K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$12.1M | -- | -- | -$296K | |
| Other Financing Activities | -$56K | -$153K | -$7.9M | -$13.6M | -$13.6M | |
| Cash From Financing | $702K | -$8.1M | $1.7M | -$10.9M | $140.7M | |
| Beginning Cash (CF) | $89.5M | $130.2M | $171.4M | $298.4M | $137.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $40.7M | $41.2M | $127M | -$160.8M | $379.9M | |
| Ending Cash (CF) | $130.2M | $171.4M | $298.4M | $137.6M | $517.6M | |
| Levered Free Cash Flow | $45M | $59.4M | $116M | $61.9M | $239.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.7M | $13.2M | $29.6M | $23.3M | $56.7M | |
| Depreciation & Amoritzation | $97K | $34K | $6.6M | $9.4M | $9.5M | |
| Stock-Based Compensation | $1.6M | $1.9M | $2.9M | $8.2M | $5.9M | |
| Change in Accounts Receivable | $386K | -$3.9M | -$23M | -$7M | -$5.8M | |
| Change in Inventories | $261K | $43K | $577K | -$4.3M | -$237K | |
| Cash From Operations | $3.8M | $8.5M | $12.1M | $31.9M | $60M | |
| Capital Expenditures | $911K | -- | $74K | $199K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.9M | -- | -$162.4M | -$199K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$2.6M | -- | -$296K | -- | |
| Other Financing Activities | -- | -- | -$1.1M | -$1.2M | -$1.7M | |
| Cash From Financing | $188K | -$1.6M | $149K | $141M | $3.1M | |
| Beginning Cash (CF) | $130.2M | $171.4M | $298.4M | $137.6M | $517.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.9M | $6.9M | -$150.1M | $172.8M | $63.1M | |
| Ending Cash (CF) | $127.3M | $178.4M | $148.2M | $310.4M | $580.7M | |
| Levered Free Cash Flow | $2.9M | $8.5M | $12M | $31.7M | $60M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $72.2M | $45.1M | $99.4M | $65.1M | $197.4M | |
| Depreciation & Amoritzation | $112K | $129K | $7.8M | $35.7M | $37.8M | |
| Stock-Based Compensation | $6.3M | $6.4M | $8.9M | $19.6M | $19.9M | |
| Change in Accounts Receivable | $1.3M | -$5M | -$22.9M | -$27.1M | -$10.8M | |
| Change in Inventories | -$2.2M | -$3.4M | $1.6M | -$9.6M | $175K | |
| Cash From Operations | $41.6M | $65M | $119.6M | $163.5M | $267.9M | |
| Capital Expenditures | $922K | $110K | $103K | $81.9M | $357K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$16.9M | -$4.1M | -$153.2M | -$131.3M | -$357K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$14.6M | $2.6M | -$296K | -- | |
| Other Financing Activities | -- | -- | -$9M | -$13.7M | -$14.1M | |
| Cash From Financing | $864K | -$9.9M | $3.4M | $130M | $2.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $25.6M | $51M | -$30.1M | $162.2M | $270.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $40.7M | $64.9M | $119.5M | $81.6M | $267.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.7M | $13.2M | $29.6M | $23.3M | $56.7M | |
| Depreciation & Amoritzation | $97K | $34K | $6.6M | $9.4M | $9.5M | |
| Stock-Based Compensation | $1.6M | $1.9M | $2.9M | $8.2M | $5.9M | |
| Change in Accounts Receivable | $386K | -$3.9M | -$23M | -$7M | -$5.8M | |
| Change in Inventories | $261K | $43K | $577K | -$4.3M | -$237K | |
| Cash From Operations | $3.8M | $8.5M | $12.1M | $31.9M | $60M | |
| Capital Expenditures | $911K | -- | $74K | $199K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.9M | -- | -$162.4M | -$199K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$2.6M | -- | -$296K | -- | |
| Other Financing Activities | -- | -- | -$1.1M | -$1.2M | -$1.7M | |
| Cash From Financing | $188K | -$1.6M | $149K | $141M | $3.1M | |
| Beginning Cash (CF) | $130.2M | $171.4M | $298.4M | $137.6M | $517.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.9M | $6.9M | -$150.1M | $172.8M | $63.1M | |
| Ending Cash (CF) | $127.3M | $178.4M | $148.2M | $310.4M | $580.7M | |
| Levered Free Cash Flow | $2.9M | $8.5M | $12M | $31.7M | $60M | |
Get CPRX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CPRX
Sector
P/E ratio
14.89x
23.51x
PEG ratio
0.08x
0.00x
P/B ratio
3.59x
1.65x
Price / LTM sales
5.50x
1.60x
Growth Metrics
CPRX
Sector
Revenue growth
43.56%
4.92%
Earnings growth
136.84%
7.49%
Revenue (5-year growth)
36.89%
8.25%
Earnings forecast
$0.55
-$0.20
Profitability
CPRX
Sector
Profitability FY 2024
$422.9M
$53.7M
Return on invested capital
29.43%
-14.69%
Return on assets
25.4%
-11.84%
Return on equity
29.43%
-17.27%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
6
Balance Sheet
CPRX
Sector
Total cash
$580.7M
$40.3M
Short term investments
--
$34.6M
Total assets
$851.4M
$119.9M
Long term debt
--
$9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Butterfly Network the Best Small-Cap Stock?
Brought to public trading by an SPAC merger in early…
Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
